6869 N Stock Overview
Engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Sysmex Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥921.96 |
| 52 Week High | JP¥1,247.91 |
| 52 Week Low | JP¥921.96 |
| Beta | 0.60 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -63.94% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6869 N | MX Medical Equipment | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how 6869 N performed against the MX Medical Equipment industry.
Return vs Market: Insufficient data to determine how 6869 N performed against the MX Market.
Price Volatility
| 6869 N volatility | |
|---|---|
| 6869 N Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: 6869 N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 6869 N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 9,500 | Hisashi Ietsugu | www.sysmex.co.jp |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Sysmex Corporation Fundamentals Summary
| 6869 N fundamental statistics | |
|---|---|
| Market cap | Mex$185.16b |
| Earnings (TTM) | Mex$5.42b |
| Revenue (TTM) | Mex$49.09b |
34.1x
P/E Ratio3.8x
P/S RatioIs 6869 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6869 N income statement (TTM) | |
|---|---|
| Revenue | JP¥419.82b |
| Cost of Revenue | JP¥196.29b |
| Gross Profit | JP¥223.53b |
| Other Expenses | JP¥177.16b |
| Earnings | JP¥46.38b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
Nov 08, 2023
| Earnings per share (EPS) | 221.57 |
| Gross Margin | 53.24% |
| Net Profit Margin | 11.05% |
| Debt/Equity Ratio | 0% |
How did 6869 N perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield36%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/07 23:18 |
| End of Day Share Price | 2023/08/10 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2023/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Sysmex Corporation is covered by 35 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yoshitsugu Sasaki | Aizawa Securities Co. Ltd. |
| Masahiro Nakanomyo | Barclays |
| Craig Nelson | BNP Paribas Securities (Asia) |